To study the efficacy of thallium-201 as tumor seeking agent and to study its role in therapeutic response
- PMID: 28790781
- PMCID: PMC5533543
- DOI: 10.1016/j.mjafi.2017.01.001
To study the efficacy of thallium-201 as tumor seeking agent and to study its role in therapeutic response
Abstract
Background: Tumour seeking characteristics of TL-201 have been underutilized. The study was undertaken to evaluate the role of TL-201 scintigraphy in tumour imaging.
Methods: A total of 50 cases were studied over a period of 18 months (13 lymphomas, 11 breast carcinoma, 10 lung cancer, 6 of soft tissue sarcoma, 2 bone tumours and 4 cases each of thyroid and brain tumours). Thallium-201 chloride was injected IV in the dose range of 3-5 mCi. Imaging was done using Siemen's ECAM dual headed gamma camera. Mean tumour to background ratio (T/B ratio) was calculated for all the positive cases. Descriptive statistical analysis was carried out.
Results: Findings revealed a sensitivity of 94.12%, specificity 87.5%, PPV 94.12%, NPV 87.50% and accuracy of 92% for TL-201 tumour imaging. The mean T/B ratio for the true positive cases at 10 min and at 3 h was 1.81 and 1.99 respectively, the difference being 0.18 (P value <0.001). Amongst them, the mean T/B ratios for low-grade tumours were 1.45 ± 0.32 at 10 min and 1.63 ± 0.38 after 3 h with difference of 0.176 (P < 0.001). For the high-grade tumours the ratios were 2.08 ± 0.35 and 2.26 ± 0.41 respectively with a difference of 0.186 (P < 0.001).
Conclusion: Thallium-201 scintigraphy is a useful tumour imaging modality in cases of thyroid, breast, brain, lung, soft tissue and bone tumours and lymphomas. A T/B ratio of 1.63 ± 0.38 in 3 h-delayed imaging is suggestive of low-grade tumours. For high-grade tumours a ratio of 2.26 ± 0.41 should be considered significant.
Keywords: Scintigraphy; T/B ratio; Thallium.
Figures
References
-
- Gehring P.J., Hammand P.B. The interrelationship between thallium and potassium in animals. J Pharmacol Exp Ther. 1967;155:187–201. - PubMed
-
- Lebowitz E., Greene M.W., Fairchild R. Thallium-201 for medical use. I. J Nucl Med. 1975;16:151–155. - PubMed
-
- Waxman A.D. Nuclear Medicine Annual. Raven Press; New York: 1991. Thallium-201 in nuclear oncology; pp. 193–209.
-
- Elgazzer A.H., Fernandez-Ulloa M., Silberstein E.B. 201-T1 as a tumour-localizing agent: current status and future considerations. Nucl Med Commun. 1993;14:96–103. - PubMed
-
- Nadel H.R. Thallium-201 for oncological imaging in children. Semin Nucl Med. 1993;23:243–254. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
